Memorial Sloan Kettering Cancer Center - Company Profile

Powered by

All the data and insights you need on Memorial Sloan Kettering Cancer Center in one report.

  • Save hours of research time and resources with
    our up-to-date Memorial Sloan Kettering Cancer Center Strategy Report

  • Understand Memorial Sloan Kettering Cancer Center position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Memorial Sloan Kettering Cancer Center: Overview

Memorial Sloan Kettering Cancer Center (MSKCC) is a healthcare service provider that offers cancer treatment, cancer research, and cancer education programs. It offers services such as research, education services, clinical trials, training services among others. The center conducts research in the therapeutic areas of bone and marrow stem cell transplantation, cancer pathology, cancer therapeutics and drug development, cell biology, cell cycle regulation, cell death, cell signaling, immunology, genetics and genomics, molecular imaging and tumor growth. It offers various cancer types such as AIDS-associated cancers acoustic neuroma, adrenal tumors, anal cancer, appendiceal cancer, basal cell carcinoma, benign blood disorders, bile duct cancer, bladder cancer, bone cancer among others. The center also offers predoctoral and postdoctoral training. It has operations in New York and New Jersey, the US. MSKCC is headquartered in New York, the US.

Gain a 360-degree view of Memorial Sloan Kettering Cancer Center and make more informed decisions for your business Gain a 360-degree view of Memorial Sloan Kettering Cancer Center and make more informed decisions for your business Find out more
Headquarters United States of America

Address 1275 York Avenue, New York City, 10065


Telephone 1 212 6392000

Industry Pharmaceuticals and Healthcare

Revenue (2022) $6.6B

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Memorial Sloan Kettering Cancer Center premium industry data and analytics

1,900+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Memorial Sloan Kettering Cancer Center’s relevant decision makers and contact details.

1,300+

Clinical Trials

Determine Memorial Sloan Kettering Cancer Center go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

960+

Investigators

Review investigator profiles and find information on trial contacts across Memorial Sloan Kettering Cancer Center, including performance indicators like number of completed trials, and linked attributes such as rehiring statistics.

540+

Catalyst Calendar

Proactively evaluate Memorial Sloan Kettering Cancer Center’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

140+

Pipeline Drugs

Identify which of Memorial Sloan Kettering Cancer Center’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

4

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

1

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Products and Services

Services
Education
Research
Training
XYZ
XYZ
XYZ
Understand Memorial Sloan Kettering Cancer Center portfolio and identify potential areas for collaboration Understand Memorial Sloan Kettering Cancer Center portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2023 Contracts/Agreements In August, the company and AI MEDICAL SERVICE INC. signed a joint research agreement in the field of gastrointestinal endoscopy AI.
2022 Contracts/Agreements In November, the company entered into an agreement with Curbside Health to improve clinical oncology pathways.
2022 Contracts/Agreements In July, the company entered a three-year research collaboration agreement with NeoPhore Limited to determine the potential of NeoPhore's proprietary DNA mismatch repair inhibitor compounds to enhance tumour immunogenicity and induce tumour immunity.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Memorial Sloan Kettering Cancer Center Abramson Cancer Center Barrett Cancer Center Radiotherapy Clinics of Georgia LLC The Center for Mind-Body Medicine
Headquarters United States of America United States of America United States of America United States of America United States of America
City New York City Philadelphia Cincinnati Conyers Washington
State/Province New York Pennsylvania Ohio Georgia WashingtonD.C.
No. of Employees - - - - -
Entity Type Institution Institution Institution Institution Institution
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Selwyn M. Vickers Chief Executive Officer; President Senior Management - -
Michael P. Harrington Chief Financial Officer; Executive Vice President Senior Management - -
Anaeze Offodile Chief Strategy Officer Senior Management - -
Erin McDonough Chief Communications Officer; Chief Marketing Officer; Senior Vice President Senior Management - -
LaKisha Mack Chief Administrative Officer Senior Management - -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Memorial Sloan Kettering Cancer Center key executives to enhance your sales strategy Gain insight into Memorial Sloan Kettering Cancer Center key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward